PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 103 filers reported holding PASSAGE BIO INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $242 | -30.1% | 367,696 | 0.0% | 0.01% | -14.3% |
Q2 2023 | $346 | -1.7% | 367,696 | 0.0% | 0.01% | -12.5% |
Q1 2023 | $352 | -30.6% | 367,696 | 0.0% | 0.01% | -42.9% |
Q4 2022 | $507 | -99.9% | 367,696 | 0.0% | 0.01% | +16.7% |
Q3 2022 | $460,000 | -36.8% | 367,696 | +19.2% | 0.01% | -45.5% |
Q2 2022 | $728,000 | -41.3% | 308,445 | -22.9% | 0.02% | -24.1% |
Q1 2022 | $1,240,000 | -48.8% | 400,000 | +5.0% | 0.03% | -47.3% |
Q4 2021 | $2,420,000 | -27.7% | 381,034 | +13.4% | 0.06% | -23.6% |
Q3 2021 | $3,347,000 | -25.6% | 336,034 | -1.1% | 0.07% | -27.3% |
Q2 2021 | $4,498,000 | -2.9% | 339,701 | +28.2% | 0.10% | -2.9% |
Q1 2021 | $4,631,000 | -39.7% | 264,911 | -11.9% | 0.10% | -31.1% |
Q4 2020 | $7,685,000 | +284.8% | 300,554 | +97.3% | 0.15% | +179.2% |
Q3 2020 | $1,997,000 | -49.5% | 152,325 | +5.3% | 0.05% | -53.1% |
Q2 2020 | $3,952,000 | +39.5% | 144,592 | -19.6% | 0.11% | +2.7% |
Q1 2020 | $2,832,000 | – | 179,796 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 4,959,769 | $4,668,631 | 5.54% |
New Leaf Venture Partners, L.L.C. | 2,497,922 | $2,348,047 | 2.02% |
BML Capital Management, LLC | 2,058,767 | $1,937,917 | 1.74% |
Lynx1 Capital Management LP | 1,167,343 | $1,098,820 | 0.72% |
Acuitas Investments, LLC | 418,173 | $393,626 | 0.23% |
Orbimed Advisors | 10,124,576 | $9,530,263 | 0.17% |
Frazier Life Sciences Management, L.P. | 1,850,000 | $1,741,405 | 0.10% |
TANG CAPITAL MANAGEMENT LLC | 300,000 | $282,390 | 0.04% |
Marquette Asset Management, LLC | 86,050 | $80,999 | 0.02% |
Annandale Capital, LLC | 54,338 | $51 | 0.02% |